Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population.

Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population. Despite therapeutic ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

Very high lipoprotein(a) levels strongly predicted long-term cardiovascular disease risk in healthy women, according to a cohort study, while mild to moderately high levels were not really red flags.

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A.

If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease. But, ...

Dear Dr. Roach: I'm a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn't need to be ...

Authors say findings call for primary prevention strategies to extend beyond traditional 10-year estimates. (HealthDay News) — A single combined measure of high-sensitivity C-reactive protein (CRP), ...

Pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) are produced in large quantities locally in the joints and subsequently enter the bloodstream. TNF-α and IL-6 may promote LDL metabolism by ...

Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk. Higher cholesterol variability correlates with a greater incidence of dementia ...